Limitations of a contemporary prostate biopsy: the blind march forward.
about
Diagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUSUnscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease.Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study.A biomedical engineering approach to mitigate the errors of prostate biopsy.Digital rectal examination can detect early prostate cancer.Molecular heterogeneity of localized prostate cancer: more different than alike.
P2860
Limitations of a contemporary prostate biopsy: the blind march forward.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Limitations of a contemporary prostate biopsy: the blind march forward.
@en
Limitations of a contemporary prostate biopsy: the blind march forward.
@nl
type
label
Limitations of a contemporary prostate biopsy: the blind march forward.
@en
Limitations of a contemporary prostate biopsy: the blind march forward.
@nl
prefLabel
Limitations of a contemporary prostate biopsy: the blind march forward.
@en
Limitations of a contemporary prostate biopsy: the blind march forward.
@nl
P2860
P1433
P1476
Limitations of a contemporary prostate biopsy: the blind march forward.
@en
P2093
John T Wei
P2860
P304
P356
10.1016/J.UROLONC.2009.12.022
P577
2010-09-01T00:00:00Z